The mark consists of a stylized human-like character with arms spread to either side, shadowed in gray, with orange, red and gold skin, gold and dark gold hair, gold, red and black eyes edged in purple, black eyebrows and a black mouth with white teeth, dressed in black pants with holes in the knees showing red skin beneath and a black vest and white shirt with the word "INFLAMMATION" written in red on the shirt. All other instances of the color white represents background and/or transparent areas and are not a feature of the mark.
Mark For: INFLAMMATION™ trademark registration is intended to cover the category of
>The color(s) gray, orange, red, gold, dark gold, black, purple and white is/are claimed as a feature of the mark. The mark consists of a stylized human-like character with arms spread to either side, shadowed in gray, with orange, red and gold skin, gold and dark gold hair, gold, red and black eyes edged in purple, black eyebrows and a black mouth with white teeth, dressed in black pants with holes in the knees showing red skin beneath and a black vest and white shirt with the word "INFLAMMATION" written in red on the shirt. All other instances of the color white represents background and/or transparent areas and are not a feature of the mark.
Research | OneLook Acronym Finder |
Serial Number | 90028312 |
Mark Literal Elements | INFLAMMATION |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-11-10 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | Novartis Pharmaceuticals Corporation |
Attorney Name | Maury M. Tepper, III |
2020-06-30 | Application Filed |
2020-07-03 | Location: NEW APPLICATION PROCESSING |
2020-07-03 | Status: Live/Pending |
2020-07-03 | Transaction Date |
2020-11-10 | Location: PUBLICATION AND ISSUE SECTION |
2020-12-15 | Published |
2020-12-15 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
Party: | Novartis AG |
Address | CH-4002 Basel SWITZERLAND 4002 |
Legal Entity Type | Aktiengesellschaft |
Legal Entity State | SWITZERLAND |
Application | MULTI | 2020-06-30 |
Drawing | JPEG | 2020-06-30 |
Design Search Code Corr Project | APPLICATION/XML | 2020-07-30 |
Notation to File | XML | 2020-10-05 |
XSearch Search Summary | XML | 2020-10-05 |
Offc Action Outgoing | MULTI | 2020-10-06 |
Amended Drawing | JPEG | 2020-10-29 |
Drawing | JPEG | 2020-10-29 |
Response to Office Action | MULTI | 2020-10-29 |
Amendment and Mail Process Complete | MULTI | 2020-11-02 |
Examiners Amendment | XML | 2020-11-05 |
Notation to File | XML | 2020-11-05 |
Amendment and Mail Process Complete | MULTI | 2020-11-06 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-11-10 |
Notice of Publication | XML | 2020-11-25 |
Notification Of Notice of Publication | XML | 2020-11-25 |
OG Publication Confirmation | XML | 2020-12-15 |
21.01.12 | Dolls; Figures, toy; Rag dolls |
040106 | Elves; Fairies; Gnomes; Leprechauns; Trolls |
210112 | Dolls; Figures, toy; Rag dolls |
IC 009. US 021 023 026 036 038. G & S: Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders
IC 041. US 100 101 107. G & S: Educational and training services, namely, conducting classes, seminars and workshops in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of ophthalmic diseases and disorders
IC 042. US 100 101. G & S: Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology
IC 044. US 100 101. G & S: Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely, assisting in the observation, monitoring, adherence and compliance of patients to medical treatments; providing health information
IC 045. US 100 101. G & S: Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of ophthalmological diseases and disorders provided via a website
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
International Codes: | 45 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | The color(s) orange, gold, dark gold, black, white and red is/are claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2020-12-15 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-12-15 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-11-25 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-11-09 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-11-05 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2020-11-05 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2020-11-05 | 93665 |
EXAMINER'S AMENDMENT ENTERED | 2020-11-05 | 88888 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-10-30 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-10-29 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-10-29 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-10-06 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-10-06 | 93665 |
NON-FINAL ACTION E-MAILED | 2020-10-06 | 6325 |
ASSIGNED TO EXAMINER | 2020-10-05 | 93665 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2020-07-30 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-07-29 | |
NEW APPLICATION ENTERED IN TRAM | 2020-07-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.